Clinical Trial Update: Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hypofractionated radiotherapy for localized prostate cancer using CyberKnife or IMRT has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Stanford University | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED